|
|
Rachel R. Caspi
J Clin Invest. 2010;
120(9):3073
doi:10.1172/JCI42440
Abstract |
Full text
| PDF
A
utoimmune and inflammatory uveitis are a group of potentially blinding intraocular inflammatory diseases that arise without a known infectious trigger and are often associated with immunological responses to unique retinal proteins. In the United States, about 10% of the cases of severe visual handicap are attributed to this group of disorders. As I discuss here, experimental models of ocular autoimmunity targeting retinal proteins have brought about a better understanding of the basic immunological mechanisms involved in the pathogenesis of uveitis and are serving as templates for the development of novel therapies.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(15)
| Title and authors |
Publication |
Year |
Local Cartilage Trauma as a Pathogenic Factor in Autoimmunity (One Hypothesis Based on Patients with Relapsing Polychondritis Triggered by Cartilage Trauma)
Carlos A. Cañas, Fabio Bonilla Abadía
|
Autoimmune Diseases
|
2012 |
Immunotherapeutic implication of IL-6 blockade
Toshio Tanaka, Tadamitsu Kishimoto
|
Immunotherapy
|
2012 |
Adalimumab specifically induces CD3+ CD4+ CD25high Foxp3+ CD127− T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study
S Calleja, M Cordero-Coma, E Rodriguez, M Llorente, M Franco, J G Ruiz de Morales
|
Eye
|
2012 |
Therapeutic Targeting of the Interleukin-6 Receptor
Toshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto
|
Annu. Rev. Pharmacol. Toxicol.
|
2012 |
Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
Toshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto
|
FEBS Letters
|
2011 |
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
Sreemanti Basu, Bonnie N. Dittel
|
Immunol Res
|
2011 |
Cytokines in Autoimmune Uveitis
Reiko Horai, Rachel R. Caspi
|
Journal of Interferon & Cytokine Research
|
2011 |
Voclosporin: a potentially promising therapeutic agent for noninfectious uveitis
Yasir Jamal Sepah, Elizabeth Harlan Michelle, Brandon Metcalf, Afsheen Khwaja, Roomasa Channa, Mohamed Ibrahim, Elham Hatef, Jangwon Heo, Jeong Lee Hee, Zubir Samsuddin Rentiya, Diana V Do, Quan Dong Nguyen
|
Ex Rev Op
|
2011 |
Understanding uveitis: The impact of research on visual outcomes
Marc D. de Smet, Simon R.J. Taylor, Bahram Bodaghi, Elisabetta Miserocchi, Philip I. Murray, Uwe Pleyer, Manfred Zierhut, Tallin Barisani-Asenbauer, Phuoc LeHoang, Sue Lightman
|
Progress in Retinal and Eye Research
|
2011 |
Cutting-Edge Issues in Autoimmune Uveitis
Roger A. Levy, Francisco Assis Andrade, Ivan Foeldvari
|
Clinic Rev Allerg Immunol
|
2011 |
|